March 24, 2026

ECOG-ACRIN study finds inferior survival among Black patients with AML, independent of cytogenetic risk

February 9, 2026

Natasha Edwin, MD, community co-chair of the ECOG-ACRIN Myeloma Committee, highlights why patients in rural areas need access to quality clinical trials

January 29, 2026

Press Release: New England Journal of Medicine publishes phase 3 PATINA (PrECOG PrE0111) trial data demonstrating a significant progression-free survival benefit with palbociclib in metastatic HR+, HER2+ breast cancer

January 21, 2026

ECOG-ACRIN study identifies high rates of vulnerability in AML patients aged 60 years or older

January 3, 2025

A delicate balance: Treating older patients with metastatic pancreas cancer (with EA2186/GIANT trial chair Efrat Dotan)

October 30, 2024

Using the geriatric assessment to actualize goal-concordant care (with EA2186/GIANT study chair Dr. Efrat Dotan)

August 25, 2023

The July/August 2023 News from ECOG-ACRIN blog is now available

June 30, 2023

The May/June 2023 News from ECOG-ACRIN blog is now available

ECOG-ACRIN Cancer Research Group